Skip to content

Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders

Using Telehealth to Expand Treatment Access for Veterans With Opioid Use Disorder (CDA 18-008)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05348317
Acronym
VetReach
Enrollment
25
Registered
2022-04-27
Start date
2022-05-19
Completion date
2026-09-30
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Dependence, Substance Use, Substance Use Disorders, Veterans

Keywords

Telehealth, Motivational Interviewing, Cognitive Behavioral Therapy, Rural Health

Brief summary

This project will pilot-test and obtain stakeholder input on a telehealth-delivered substance use disorder (SUD) care model (with initial engagement and ongoing MI-CBT treatment) with the goal of increasing treatment utilization and improving outcomes for rural and non-rural Veterans with SUDs.

Interventions

BEHAVIORALVetReach

Telehealth-delivered MI-CBT substance use disorder care model

Sponsors

VA Office of Research and Development
Lead SponsorFED
VA Ann Arbor Healthcare System
CollaboratorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Veteran patients at the Ann Arbor VA Healthcare System * Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month * Telephone access * Able to provide informed consent

Exclusion criteria

* Receiving SUD psychotherapy * Inability to speak or understand English * Substantial mental health instability or conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content * Prior alcohol withdrawal seizures or delirium tremens

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the intervention (engagement)8 weeksPercent (%) of participants engaging in the intervention (at least 3 completed sessions)
Acceptability of the telehealth intervention2 monthsStudy-specific acceptability rating completed by participants (% with a positive rating, higher % is better)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLewei Lin, MD

VA Ann Arbor Healthcare System, Ann Arbor, MI

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026